Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PDD expanded its vaccine sciences lab in Richmond enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ growing research needs.
read more
EMED announced the SCIg60 Infusion System has been granted expanded indications as the only Immune Globulin Subcutaneous mechanical pump infusion system cleared by the FDA.
read more
Endpoint Clinical and Clinical Ink have teamed up to integrate IRT and eSource in order to create a seamless user experience for investigator sites.
read more
Worldwide Clinical Trials announced the appointment of Karen Nowatkoski as Vice President of Clinical Operations, Site Management.
read more
Pierre Fabre announced a purchase agreement to acquire several assets from biotechnology company Igenica Biotherapeutics.
read more
LSNE Contract Manufacturing announced they have signed a manufacturing supply agreement with Selecta Biosciences.
read more
Recro Gainesville has expanded its capabilities by adding a new tablet manufacturing suite and growing its development team.
read more
JSR Life Sciences announced KBI Biopharma is expanding its biopharmaceutical manufacturing capacity and capabilities at both its Durham, North Carolina and Boulder, Colorado facilities.
read more
CURE announced it has received their first purchase order from their recently announced agreement with Meroven for the development of OTF delivery for several molecules.
read more
Lysogene announced it has entered into a manufacturing agreement with viral gene and cell therapy manufacturer Brammer Bio.
read more
Hovione will initiate recruitment for its Phase 1 clinical trial of HY02, a proprietary minocycline sterile ointment to treat a subset of ocular surface inflammation, generally manifesting on the inner edge of the eyelids, leading to eye irritation ...
read more
ValSource announced Dr. James Vesper has joined as a Director, Learning Solutions.
read more
Recipharm has appointmented Shabbir Mostafa to its Business Management team.
read more
Saphetor announced a research partnership with the Exome Consortium of Link (UCL), led by Dr. Vincent Plagnol.
read more
Avista Pharma announced MMRF has contracted the company to manufacture an opioid-derived small molecule, a key component of a conjugate vaccine in development to treat opioid addiction.
read more